Hepatitis B Challenge Dose in Adults (V232-059-10)

NCT01251276 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
204
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Merck Sharp & Dohme LLC